Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.09%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
1.60 Up 0.04(2.56%) Dec 9, 4:00PM EST
Prev Close:1.56
Open:1.58
Bid:1.50 x 2000
Ask:4.00 x 400
1y Target Est:7.00
Beta:2.69574
Earnings Date:Mar 1 - Mar 6 (Est.)
Day's Range:1.57 - 1.65
52wk Range:1.48 - 5.40
Volume:141,186
Avg Vol (3m):98,741
Market Cap:32.80M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTXUp 2.56%32.80M
BAXUp 1.72%24.39B
OSIRUp 5.06%186.05M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.29
Quarterly EPS Est (Dec-16) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback